It appears my advice to "wait and see" what happens was a good idea.
I would issue the same advice for awhile. Wait and see what information comes forward about all the players in this "new company"
If a person had bought CNAB yesterday, they would already be in the red. While I can't see into the future, I think it is doubtful this thing will run really quick.
It did run like crazy under the ticker MYSK at the beginning of the year but it doesn't seem reasonable to assume the same thing can happen. This is a completely different company, in a completely different business. Not to mention the background of the guy in charge, Paul Enright, should be looked into.
As most know, the SEC is closely monitoring the cannabis OTC companies which adds to the other reason someone should advance with caution.